Present status of cancer chemotherapy.
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000378:metabolism; D005069:Evaluation Studies as Topic; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D008938:Mitosis; D008939:Mitotane / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011344:Procarbazine / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D004273:DNA, Neoplasm; D007093:Imidazoles; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D008939:Mitotane; D002330:Carmustine; D006918:Hydroxyurea